Sterne Agee Still Has Confidence In Actavis plc - Enact Holdings (NASDAQ:ACT)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a report published Wednesday, Sterne Agee analyst Shibani Malhotra reiterated a Buy rating and $272.00 price target on

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Actavis plc

(NYSE: ACT).In the report, Sterne Agee noted, “Although Actavis failed to garner support at today's FDA AdCom for the product, we do not see this as being very meaningful to longer-term growth and earnings potential. Per our estimates, removing this product from our revenue estimates decreases our 2018E EPS by less than 1% (see Exhibit 1 below). We believe that the company still has many levers to drive meaningful EPS growth and easily reach its 2017 EPS target of ~$20.”Actavis closed on Tuesday at $232.61.